×

Network disruptions

We have been experiencing disruptions on our local network which has affected the stability of these web pages. We have been working with IT support team to get this fixed as a matter of urgency and apologise for any inconvenience.

PDB Information

PDB6G5F
MethodX-RAY DIFFRACTION
Host OrganismEscherichia coli BL21(DE3)
Gene SourceClostridium botulinum
Primary Citation
Engineered botulinum neurotoxin B with improved binding to human receptors has enhanced efficacy in preclinical models.
Elliott, M., Favre-Guilmard, C., Liu, S.M., Maignel, J., Masuyer, G., Beard, M., Boone, C., Carre, D., Kalinichev, M., Lezmi, S., Mir, I., Nicoleau, C., Palan, S., Perier, C., Raban, E., Zhang, S., Dong, M., Stenmark, P., Krupp, J.
Sci Adv
HeaderToxin
Released2018-03-29
Resolution2.500
CATH Insert Date20 Jan, 2019

PDB Images (5)

PDB Prints

PDB Chains (3)

Chain ID Date inserted into CATH CATH Status
A 20 Jan, 2019 Chopped
B 20 Jan, 2019 Write scan list
P 20 Jan, 2019 Rejected

CATH Domains (1)

Domain ID Date inserted into CATH Superfamily CATH Status
6g5fA00 21 Jan, 2019 3.90.1240.10 Assigned

UniProtKB Entries (3)

Accession Gene ID Taxon Description
P10844 BXB_CLOBO Clostridium botulinum Botulinum neurotoxin type B
P21579 SYT1_HUMAN Homo sapiens Synaptotagmin-1
P10844 BXB_CLOBO Clostridium botulinum Botulinum neurotoxin type B
CATH-Gene3D is a Global Biodata Core Resource Learn more...